327046-67-3 Usage
Uses
Used in Pharmaceutical Research:
3-AMINO-4-TERT-BUTOXYCARBONYLAMINO-BENZOIC ACID METHYL ESTER is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure allows it to be a building block for the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
In the field of organic synthesis, 3-AMINO-4-TERT-BUTOXYCARBONYLAMINO-BENZOIC ACID METHYL ESTER serves as a versatile reagent for the preparation of a variety of organic compounds. Its ester functionality and amino groups enable it to participate in numerous chemical reactions, facilitating the synthesis of complex organic molecules.
Used in Chemical Industry:
3-AMINO-4-TERT-BUTOXYCARBONYLAMINO-BENZOIC ACID METHYL ESTER is utilized in the chemical industry for the production of specialty chemicals and materials. Its properties make it suitable for use in the development of new chemical processes and the creation of innovative products.
It is crucial to handle 3-AMINO-4-TERT-BUTOXYCARBONYLAMINO-BENZOIC ACID METHYL ESTER with care due to its potential health and environmental risks. Proper safety precautions, including the use of personal protective equipment and adherence to safety guidelines, should be taken when working with 3-AMINO-4-TERT-BUTOXYCARBONYLAMINO-BENZOIC ACID METHYL ESTER to minimize any risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 327046-67-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,7,0,4 and 6 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 327046-67:
(8*3)+(7*2)+(6*7)+(5*0)+(4*4)+(3*6)+(2*6)+(1*7)=133
133 % 10 = 3
So 327046-67-3 is a valid CAS Registry Number.
InChI:InChI=1S/C13H18N2O4/c1-13(2,3)19-12(17)15-10-6-5-8(7-9(10)14)11(16)18-4/h5-7H,14H2,1-4H3,(H,15,17)
327046-67-3Relevant articles and documents
NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF
-
Paragraph 0133; 0134; 0138, (2013/03/28)
The present invention relates to novel benzodiazepinone compounds of Formulae (I) wherein R1, R2, R4, R6, R7, R8, R9, and R10 are as defined herein. The invention also
PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM
-
Page 441, (2008/06/13)
The invention provides low molecular compounds having activity which inhibits binding of CCR3 ligands to CCR3 on target cells, i.e. CCR3 antagonists. The invention also provides compounds represented by formula (I) below, pharmaceutically acceptable acid adducts thereof, or pharmaceutically acceptable C1-C6 alkyl adducts thereof, as well as pharmaceutical compositions comprising them as effective ingredients, which are useful for treatment or prevention of diseases associated with CCR3, such as asthma and allergic rhinitis.
Inhibitors of factor Xa
-
, (2008/06/13)
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds of formula (I) below: are useful in vitro or in vivo for preventing or treating coagulation disorders.